Provided by Tiger Trade Technology Pte. Ltd.

BioLine Rx

2.51
-0.0595-2.32%
Post-market: 2.510.00000.00%16:10 EDT
Volume:10K
Turnover:24.26K
Market Cap:12.17M
PE:-1.59
High:2.62
Open:2.58
Low:2.50
Close:2.57
52wk High:4.56
52wk Low:2.15
Shares:4.85M
Float Shares:4.59M
Volume Ratio:0.55
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5822
EPS(LYR):-0.2856
ROE:-55.27%
ROA:-19.82%
PB:0.88
PE(LYR):-8.79

Loading ...

Israel's BioLineRx Q2 Net Loss Widens on Higher R&D Expenses

Reuters
·
Aug 31

BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate

Benzinga Earnings
·
Aug 31

Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 31

BioLine RX Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Aug 28

BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor

TIPRANKS
·
Jul 08

JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
Jun 02

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

BioLine Rx Q1 Sales $477.000K Beat $343.000K Estimate

Benzinga Earnings
·
May 27

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

BioLine RX Ltd expected to post a loss of $1.04 a share - Earnings Preview

Reuters
·
May 25

BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM

TIPRANKS
·
May 19

BioLine Rx Q4 EPADS $(0.34) Beats $(0.54) Estimate, Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 24

BioLine Rx Q4 Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 23

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 20

Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings

Benzinga_recent_news
·
Mar 20

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 17